Mereo BioPharma Faces Securities Lawsuit Over Failed Drug Trial Disclosures
Rosen Law Firm urges MREO investors to join class action over alleged misleading statements regarding setrusumab Phase 3 trial failures.
MREOinvestor lossessecurities class action